All Type of News
National health insurance to undergo major overhaul
The Ministry of Health and Welfare said Thursday that a working committee, which was established on Dec. 29, will review a variety of regulations concerning health insurance premiums, medical bills, quality of medical...
Civic group calls for scrapping of market based incentive system
The Citizens' Coalition for Economic Justice (CCEJ) said Wednesday that the current drug pricing system, designed to offer hospitals and pharmacies an incentive to purchase drugs from pharmaceutical companies as cheap...
Wholesalers may benefit from drug logistic cooperative
Pharmaceutical wholesalers may save their logistics costs by 30.6 percent, if they join the planned Korea Drug Logistic Cooperative, according to Sungji Logistics Management Research Institute that conducted a feasibi...
Two drugmakers to be made public by FTC
Korea’s antitrust regulator announced Wednesday that Myungmoon Pharmaceutical Co. was found to have provided 3.6 billion won to doctors and hospitals in return for prescribing, purchasing or recommending their product...
Ilyang’s new leukemia drug approved in Korea
Local drugmaker Ilyang Pharmaceutical said Thursday that the Korea Food and Drug Administration has approved its highly-anticipated leukemia medicine, the 18th-domestically-made medication.
The drug will be indicat...
Radotinib to take on Gleevec, Sprycel
Radotinib is Korea’s 18th homegrown leukemia drug and the world’s fifth and was approved by the Korea Food and Drug Administration on January 4.
Market watchers say the new drug is likely to bring a huge change to ...
Can Rhu Duk-hee retake the helm of KPMA?
Keen attention has been paid to the re-appointment of Rhu Duk-hee, incumbent chairman of the Korea Pharmaceutical Manufacturers Association and chairman of Kyungdong Pharmaceutical Co.
According to industry observe...
Doctors to file class suit against National Health Insurance Corp.
The improper refunding of medical service fees by the National Health Insurance Corporation was upheld in the Supreme Court on Nov. 24, 2011.
The court upheld the ruling that doctors may claim other treatment fees ...
Key word for drugmakers in 2012 is survival through innovation and R&D
The country’s pharmaceutical companies face tough times ahead with the government’s plan to slash drug prices starting April, heaping strain on the generic-focused Korean industry.
Currently, Korean firms remain ji...
CJ to work with BioLeaders on cancer and vaccine research
CJ Cheil Jedang and BioLeaders Corp. on Dec. 30 signed an agreement to collaborate on joint projects of cancer and vaccine at BioLeaders's headquarters in Daejeon, following a memorandum of understanding executed on O...
